Literature DB >> 8186666

Role of endothelin in hypertension.

B K Krämer1, M Ackermann, S M Kohler, G A Riegger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8186666     DOI： 10.1007/bf00184582

Source DB:  PubMed          Journal:  Clin Investig        ISSN： 0941-0198


× No keyword cloud information.
  76 in total

1.  The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta.

Authors:  M L Webb; K E Dickinson; C L Delaney; E C Liu; R Serafino; R B Cohen; H Monshizadegan; S Moreland
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

2.  Hypertension associated with endothelin-secreting malignant hemangioendothelioma.

Authors:  K Yokokawa; H Tahara; M Kohno; K Murakawa; K Yasunari; K Nakagawa; T Hamada; S Otani; M Yanagisawa; T Takeda
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

3.  Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats.

Authors:  L H Mortensen; G D Fink
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

Review 4.  Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.

Authors:  L J Ignarro
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

5.  Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells.

Authors:  T E Bunchman; C A Brookshire
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Sarafotoxins S6: several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart.

Authors:  C Takasaki; N Tamiya; A Bdolah; Z Wollberg; E Kochva
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

7.  Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.

Authors:  A C Le Monnier de Gouville; S Mondot; H Lippton; A Hyman; I Cavero
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

8.  Endothelin is a potent mitogen for rat vascular smooth muscle cells.

Authors:  Y Hirata; Y Takagi; Y Fukuda; F Marumo
Journal:  Atherosclerosis       Date:  1989-08       Impact factor: 5.162

9.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

10.  Endothelin is a potent long-lasting vasoconstrictor in men.

Authors:  J G Clarke; N Benjamin; S W Larkin; D J Webb; G J Davies; A Maseri
Journal:  Am J Physiol       Date:  1989-12
View more
  3 in total

1.  Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis.

Authors:  K Becker; W Erdbrügger; I Heinroth-Hoffmann; M C Michel; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Endothelin-1 does not prime polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites.

Authors:  S Kopprasch; A Gatzweiler; M Kohl; H E Schröder
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

3.  Multimodal assessment of recovery from coma in a rat model of diffuse brainstem tegmentum injury.

Authors:  Patricia Pais-Roldán; Brian L Edlow; Yuanyuan Jiang; Johannes Stelzer; Ming Zou; Xin Yu
Journal:  Neuroimage       Date:  2019-01-29       Impact factor: 7.400
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.